- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT03671863
Children Born With Club Feet (CBCF)
Children Born With Club Feet: Ultrasound Diagnosis and Antenatal Assessment
Clubfoot is one of the most common birth defects, with a prevalence in Europe estimated between 1 and 4.5 for 1000 live birth.
It is useful to distinguish the forms of isolated clubfoot, and the forms related to others morphological abnormalities (complex clubfoot). For the complex forms, the clubfoot can be integrated in a syndromic association, be the consequence of a serious harm of the central nervous system, be associate to a genetic musculo-skeletal disease or wether be associated to a karyotype abnormality.
In those cases, the prognosis depends more about the associated morphological abnormalities that can be the beginning of a severe disability or incompatible with life or any anomaly of the karyotype that clubfoot itself.
In case of several morphological abnormalities, to propose invasive samples with realization of a karyotype and chromosome analysis with CGH array is a consensual attitude.
What the investigators should recommended to the parents in case of isolated form is less obvious and the question of antenatal investigations can not be answered clearly in the literature. Thus, the management of these patients may vary from one CPDP to another.
This study project will make it possible to analyze the management offered to patients whose fetuses have club feet and to study the results of the various examinations carried out in order to adapt the prenatal counselling and to define the best diagnostic strategy to propose to the future parents.
Study Overview
Status
Conditions
Intervention / Treatment
Study Type
Enrollment (Actual)
Contacts and Locations
Study Locations
-
-
-
Montpellier, France, 34295
- Uhmontpellier
-
-
Participation Criteria
Eligibility Criteria
Ages Eligible for Study
Accepts Healthy Volunteers
Genders Eligible for Study
Sampling Method
Study Population
Description
Inclusion criteria:
- Congenital clubfoot uni or bilateral
- Have been treated in the reference center " Institut Saint Pierre, Plavas-les-flots, France "
Exclusion criteria:
- Non confirmed clubfoot after birth
Study Plan
How is the study designed?
Design Details
- Observational Models: Cohort
- Time Perspectives: Retrospective
Cohorts and Interventions
Group / Cohort |
Intervention / Treatment |
---|---|
Infants who are treated for clubfoot
Infants who are treated for clubfoot in the reference reeducation center
|
Invasive analysis (caryotype, CGH array)
Prenatal management
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
---|---|---|
Antenatal detection rate of clubfeet
Time Frame: At birth
|
Antenatal detection rate of clubfeet in percentage
|
At birth
|
Secondary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
---|---|---|
Rate of isolated clubfoot among children followed for clubfoot
Time Frame: At birth
|
Rate of isolated clubfoot among children followed for clubfoot in percentage
|
At birth
|
Rate of refered for second-degree examination
Time Frame: At birth
|
Rate of refered for second-degree examination in percentage
|
At birth
|
Rate of invasive samples taken and their results
Time Frame: At birth
|
Rate of invasive samples taken and their results in percentage
|
At birth
|
Rate of files submitted to our reference center committee
Time Frame: At birth
|
Rate of files submitted to our reference center committee in percentage
|
At birth
|
Research rates of musculoskeletal genetic disease
Time Frame: At birth
|
Research rates of musculoskeletal genetic disease in percentage
|
At birth
|
Rate of consultation with geneticist
Time Frame: At birth
|
Rate of consultation with geneticist in percentage
|
At birth
|
Rate of consultation with a orthopedic surgeon
Time Frame: At birth
|
Rate of consultation with a orthopedic surgeon in percentage
|
At birth
|
Collaborators and Investigators
Sponsor
Investigators
- Principal Investigator: Florent FUCHS, PhD, University Hospital, Montpellier
Study record dates
Study Major Dates
Study Start (Actual)
Primary Completion (Actual)
Study Completion (Actual)
Study Registration Dates
First Submitted
First Submitted That Met QC Criteria
First Posted (Actual)
Study Record Updates
Last Update Posted (Actual)
Last Update Submitted That Met QC Criteria
Last Verified
More Information
Terms related to this study
Additional Relevant MeSH Terms
Other Study ID Numbers
- RECHMPL18_0332
Plan for Individual participant data (IPD)
Plan to Share Individual Participant Data (IPD)?
IPD Plan Description
Drug and device information, study documents
Studies a U.S. FDA-regulated drug product
Studies a U.S. FDA-regulated device product
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Clubfoot
-
LiMingHunan Children's Hospital; Guangzhou Women and Children's Medical Center; Shenzhen...Unknown
-
Texas Scottish Rite Hospital for ChildrenRecruiting
-
University of British ColumbiaCompletedIdiopathic Clubfoot (Talipes Equinovarus)Canada
-
University of British ColumbiaCompletedIdiopathic Clubfoot (Talipes Equinovarus)Canada
-
Washington University School of MedicineShriners Hospitals for ChildrenCompletedIsolated ClubfootUnited States
-
Guangzhou Women and Children's Medical CenterUnknown
-
The Hospital for Sick ChildrenCompleted
-
University of British ColumbiaCompleted
-
Children's Hospital of Chongqing Medical UniversityCompleted
Clinical Trials on Invasive analysis (caryotype, CGH array)
-
Central Hospital, Nancy, FranceUnknownGenetic Disease | IUGR | Prenatal Disorder
-
Central Hospital, Nancy, FranceUnknownClubfoot | Prenatal Disorder
-
University Hospital, Strasbourg, FranceRecruitingPregnancy Related | Rare Genetic Disease | Fetal MalformationFrance
-
ReprogeneticsMcGill University; Yale University; Reprogenetics Lationoamerica S.A.C, Lima,... and other collaboratorsTerminatedInfertility | MiscarriagePeru
-
Instituto Valenciano de Infertilidad, IVI VALENCIACompleted
-
Gynecologic Oncology GroupNational Cancer Institute (NCI)WithdrawnOvarian Serous Cystadenocarcinoma | Stage IIIA Ovarian Cancer | Stage IIIB Ovarian Cancer | Stage IIIC Ovarian Cancer | Stage IV Ovarian Cancer | Ovarian Serous Surface Papillary AdenocarcinomaUnited States
-
National Taiwan University HospitalRecruitingPain | Anesthesia | EEGTaiwan
-
Abbott Medical DevicesCompletedCoronary Artery Disease | Coronary StenosisUnited States
-
Lund University HospitalGöteborg University; Region Jönköping CountyActive, not recruitingCardiovascular Diseases | Atrial Septal Defect | Patent Ductus Arteriosus | Ventricular Septal Defect | Aortopulmonary Window | Heart Disease Congenital | Partial Anomalous Pulmonary Venous ConnectionSweden